Aim: The activation of RhoA and Rac1 is crucial for the pathogenesis of atherosclerosis. This study investigated the changes of unprocessed and mature forms of RhoA and Rac1 in the progression of atherosclerosis. Methods: Unprocessed and geranylgeranylated forms of RhoA and Rac1 in aortic atherosclerotic lesions were separated by the Triton X-114 partition method using Watanabe heritable hyperlipidemic (WHHLMI) rabbits prone to myocardial infarction. The activation of RhoA and Rac1 was determined by membrane translocation and pull-down assays. Results: The levels of unprocessed RhoA and Rac1 of the aortas were higher at 7 months than 3 months, accompanied by increased levels of total RhoA and Rac1. Membrane-bound RhoA and Rac1 levels of the aortas at 7 months were significantly increased compared with those at 3 months, consistent with the results of GTP-loading. Unprocessed and activated forms of RhoA and Rac1 had gradually decreas at 15 and 24 months compared to 7 months. Conclusions: We show evidence of marked increases in unprocessed RhoA and Rac1 with enhanced activities in the progression of atherosclerosis in WHHLMI rabbits. This is important for better understanding of the pathogenesis of hyperlipidemia-dependent atherosclerosis. J Atheroscler Thromb, 2009; 16:846-856.
Introduction
In the Ras homolog gene family, member A (RhoA) is a small GTPase protein known to regulate the actin cytoskeleton in the formation of stress fibers. Rac1 (Ras-related C3 botulinum toxin substrate1) is a small (~21 kDa) GTPase protein, a member of the Rac subfamily of the Rho family of GTPases. This molecule is a pleiotropic regulator of many cellular processes including the cell cycle, cell-cell adhesion of unprocessed RhoA in thrombin-stimulated endothelial cells 9) .
It has been shown that RhoA and Rac1 are expressed in the remodeled vascular wall in vivo 3, [10] [11] [12] . Protein levels of RhoA reportedly increase several-fold in an atherogenic animal model of apolipoprotein E-deficient mice compared with wild-type control mice 11) . Moreover, physical activity decreases Rac1 activity, ROS generation and atherosclerotic lesion formation in atherogenic mice 12) ; however, little is known about the profiles of unprocessed and geranylgeranylated RhoA and Rac1 and the activities of these molecules in the progression of atherosclerosis.
This study investigated the proportions of unprocessed and geranylgeranylated RhoA and Rac1 as well as the activities of the two molecules in the progression of atherosclerosis using a novel atherosclerosis animal model of Watanabe heritable hyperlipidemic (WHHLMI) rabbits prone to myocardial infarction which spontaneously develop atherosclerosis 13, 14) .
Methods

Materials
The sources of most conventional reagents for protein and immunohistochemical analyses were described previously 8, 9, 15, 16) .
Animals
Male and female WHHLMI rabbits with no sexrelated differences in atherosclerosis were bred at the Institute for Experimental Animals, Kobe University Graduate School of Medicine. The animals were kept in rooms equipped with laminar-flow filters at a temperature of ~22 and were fed standard rabbit chow in the Experimental Animal Laboratory of Fukushima Medical University 13, 15) .
Study Protocol
Three-to 24-month-old WHHLMI rabbits were selected on the basis of their serum cholesterol levels, which ranged from 13.0 to 18.1 mmol/L, to make the degrees of atherosclerosis 13, 17) . Rabbits were euthanized by an intravenous injection of 50 mg/kg sodium pentobarbital. After perfusion−fixation, thoracic aortas of rabbits were removed and used for histological and immunohistochemical analyses of atheromatous plaques and the objectives described below. We examined the expression of RhoA and Rac1 in the aortas, as determined by fluorescent immunohistochemistry. Unprocessed and geranylgeranylated forms of RhoA and Rac1 of the aortas at the ages of 3, 7, 15 and 24 months were separated by the Triton X-114 partition method and their levels were determined by Western blotting. We performed membrane translocation and pull-down assays to determine the activities of RhoA and Rac1 of the aortas at 3, 7 and 15 months, whereas the activity of p47 phox , another component of NADPH oxidase, was determined by membrane translocation. These experiments were carried out under the control of the Animal Research Committee in accordance with the Guidelines on Animal Experiments of Fukushima Medical University and the Japanese Government Animal Protection and Management Law (No. 105), as well as the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).
Histological Analysis
Rabbits were anesthetized and perfused with lactated Ringer's solution and then Bouin's fixative using perfusion apparatus at a constant pressure of 100 mmHg. After perfusion−fixation, atherosclerotic lesions of the aortas were excised and then immersed in Bouin's fixative for at least 24 hours. After immersion−fixation, atherosclerotic lesions were embedded in paraffin and cut into 4-m-thick sections. The sections were used for Azan-Mallory and hematoxylin and eosin (H&E) staining, and fluorescent immunohistochemistry 13, 15) .
Fluorescent Immunohistochemistry of RhoA and Rac1
The sections were incubated for 60 minutes at room temperature with mouse monoclonal antibodies against RhoA diluted 1:200 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), Rac1 (Upstate Biotechnology, Lake Placid, NY) diluted 1:200, smooth muscle actin diluted 1:100 (1A4, Dako, Carpinteria, CA) and macrophages (RAM-11; Dako) diluted 1:200. After washing three times, the sections were incubated for 45 minutes at room temperature with a goat antimouse IgG antibody conjugated with fluorescein isothiocyanate (Santa Cruz Biotechnology) using a spectral imaging fluorescence microscope system (OLYM-PUS Optical Co., Ltd., Tokyo, Japan).
Separation of Unprocessed and Geranylgeranylated RhoA and Rac1
Unprocessed and geranylgeranylated forms of RhoA and Rac1 were separated by the Triton X-114 partition method as described previously 9) . The aortas were cut into small pieces and solubilized with a buffer containing 50 mmol/L Tris-HCl pH 7.5, 150 mmol/L NaCl, 5 mmol/L MgCl2, 200 mol/L GDP, 1 mmol/L dithiothreitol, 1 mmol/L pefabloc, 20 mol/L each of leupeptin, aprotinin and soybean trypsin inhibitor, and then sonicated. Triton X-114 (11% (w/v)) was added to the lysates to a final concentration of 1% (v/v). The lysates were mixed for 10 minutes at 4 and centrifuged at 15,000 g at 4 for 30 minutes to remove insoluble materials. The supernatant was warmed at 37 until it became cloudy, and then centrifuged at 400 g for 4 minutes at room temperature to separate the upper (unprocessed) phase from the lower (geranylgeranylated) phase. Both phases were adjusted to 1% (v/v) Triton X-114 on ice, and protein concentrations were determined by the Bradford method. The protein levels of RhoA and Rac1 were determined by Western blotting, followed by densitometric analysis. Briefly, aliquots containing 20 g protein were subjected to electrophoresis, and the proteins were then transferred to polyvinylidene difluoride membranes. After incubating with blocking solution at room temperature for 30 minutes, the membranes were incubated for 60 minutes at room temperature with mouse monoclonal antibodies against RhoA diluted 1:250 and Rac1 diluted 1:500, followed by incubation with horseradish peroxidase-conjugated goat anti-mouse IgG (Santa Cruz Biotechnology). Signals from immunoreactive bands were visualized by fluorography with an Amersham ECL TM System (Amersham Pharmacia Biotech UK Ltd., Buckinghamshire, England).
Membrane Translocation of RhoA, Rac1 and p47 phox
The protein levels of RhoA and Rac1 in membrane fractions of the aortas were determined as described previously 8, 16) . For the preparation of membrane fractions of aortas, the isolated aortas were cut into small pieces, solubilized with a hypotonic buffer (10 mmol/L Tris, 2 mmol/L EDTA, 20 g/mL antipain, 20 g/mL leupeptin, 1 mol/L DTT, and 1 mol/L PMSF) and centrifuged at 15,000 g for 10 minutes at 4 , followed by Western blotting.
GTP-loading of RhoA and Rac1
The levels of GTP-bound forms of RhoA and Rac1 of the aortas were determined by pull-down assays as described previously 8, 9, 18) . The removed aortas were cut into small pieces and lysed in a buffer (50 mmol/L Tris, pH 7.2, 500 mmol/L NaCl, 10 mmol/L MgCl2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 20 g/mL antipain, 20 g/mL leupeptin, and 1 mmol/L PMSF). After centrifugation at 18,000 g at 4 for 10 minutes, the extracts were incubated for 45 minutes at 4 with glutathione-Sepharose 4B beads coupled with glutathione-S-transferase (GST)-rhotekin fusion protein for determina-tion of RhoA activity and GST-p21-activated kinase (PAK) for Rac1 activity. Bound RhoA and Rac1 proteins were quantitated by Western blotting as described above.
The activity ratios of RhoA and Rac1 of the aortas at the ages of 3, 7 and 15 months were determined by dividing the levels of RhoA and Rac1 in the membrane fractions by the total cellular levels of RhoA and Rac1.
Preparation of Oxidized Low-Density Lipoproten (LDL)
Human LDL was isolated from sera of fasting normolipidemic volunteers by sequential ultracentrifugation, and oxidized LDL was prepared by incubating native LDL for 24 hours at 4 in phosphatebuffered saline (PBS) containing 5 mol/L CuSO4, and then extensively dialyzed against PBS and sterilized by filtration as described previously 19) .
Densitometric Analysis
After scanning blots onto a computer (EPSON GT5500ART), individual bands were analyzed for optical density using NIH image as described previously 9, 20) . The area analyzed for each band was kept constant for each blot analyzed. Background density was subtracted from the densitometric data of each band.
Statistical Analysis
Statistical analyses were performed using ANOVA with Scheffé's post hoc test and Student's unpaired t test, as appropriate. A level of p 0.05 was considered significant. Data are expressed as the means SD. Fig. 1A shows photomicrographs of the aortic atherosclerotic lesions in WHHLMI rabbits at 3, 7, 15 and 24 months by Azan-Mallory staining. Early atherosclerotic lesions were noted at 3 months with macrophage infiltration into the superficial portion.
Results
Histological Analysis
Smooth muscle cell infiltration and extracellular matrix deposit were already in progress. Lesion formation markedly progressed at the age of 7 months with abundant cellular infiltration of macrophages and smooth muscle cells (SMCs), and foam cell formation was prominent. Macrophages and foam cells were observed in the media. In contrast, atheromatous lesions at the ages of 15 and 24 months had decreased cellular components of macrophages and SMCs with increases in collagen fibers, extracellular lipid deposits, cholesteryl crystals, and calcification.
RhoA and Rac1 in Aortic Atherosclerotic Lesions
Fluorescent immunohistochemistry of the atherosclerotic lesions at 7 months demonstrated that RhoA and Rac1 expression was noted in the atherosclerotic lesions and primarily colocalized with SMCs and macrophages ( Fig. 1B) .
Proportions of Unprocessed and Geranylgeranylated RhoA and Rac1 with Aging
We examined the proportions of the unprocessed and geranylgeranylated forms of RhoA and Rac1 in atherosclerotic lesions of the aortas at 3, 7, 15 and 24 months, as determined by the Triton X-114 partition method. The percentages of the unprocessed and geranylgeranylated forms of RhoA at 3 months were 25 10% and 75 10%, whereas at the age of 7 months the proportions of unprocessed RhoA had markedly increased to 75 10% with decreased values of 25 10% of geranylgeranylated RhoA ( Fig. 2A, 2B , n 4, p 0.01). At the ages of 15 and 24 months, the proportions of unprocessed and geranylgeranylated RhoA were similar to those at age of 7 months (15 months, 81 6% and 19 6%; and 24 months, 78 7% and 22 7%, n 4, p 0.01, each) as shown in Fig. 2C,  2D .
Interestingly, the levels of unprocessed RhoA were markedly increased 6.6-, 4.6-and 2.5-fold with aging at 7, 15 and 24 months compared with at 3 months ( Fig. 2E, n 4, p 0.005) . In contrast, the proportions of geranylgeranylated RhoA at 7, 15 and 24 months were significantly decreased compared to at 3 months ( Fig. 2F, n 4, p 0 .005). The total amounts of RhoA increased with aging and peaked at 7 months (1.8-fold) compared with at 3 months (Fig. 2G, n 4 , p 0.05), and a gradual decrease was noted with further aging after 7 months (Fig. 2G, 7 months vs. 24 Thoracic aortas of the rabbits were removed at 3, 7, 15 and 24 months, and the sections were stained with Azan-Mallory staining. B Representative photomicrographs of fluorescent immnohistochemistry of RhoA, Rac1 smooth muscle actin and macrophages (RAM-11) in atherosclerotic lesions of the aortas of WHHLMI rabbits at 7 months, as well as H&E staining. Fig. 3A to 3D, n 4, p 0.01, each). The amounts of unprocessed Rac1 were increased 5.5-, 4.5-and 4.7-fold with aging at 7, 15 and 24 months compared with at 3 months and the percentages of geranylgeranylated Rac1 were significantly decreased after 7 months ( Fig. 3E, 3F , n 4, p 0.005, each). The total amounts of Rac1 were increased with aging, similar to RhoA, with the peak value at 7 months (1.8 folds) compared with at 3 months ( Fig. 3G) .
Activities of RhoA and Rac1 with Aging in Atherosclerotic Lesions
Next, we examined the activities of RhoA and Rac1 in atherosclerotic lesions of WHHLMI rabbit aortas at the ages of 3, 7 and 15 months as determined by membrane translocation. The protein levels of RhoA and Rac1 in membrane fractions of the aortas at 7 months with advanced atherosclerotic lesions were markedly increased compared with at 3 months ( Fig. 4A, 4D, n 4, p 0.05, each) . At the age of 15 months the increased protein levels of membranebound RhoA and Rac1 had almost returned to the levels at 3 months ( Fig. 4A, 4D , n 4, p 0.05, each). Fig. 4B, 4E show an increase in total RhoA and Rac1, respectively (n 4, p 0.05, each). These results represented the activity ratios of RhoA and Rac1 (Fig. 4C,  4F) , indicating that the activities of RhoA and Rac1 at 7 months with accumulated atherosclerotic lesions were significantly enhanced compared with at 3 To determine indirectly the activity of guanine nucleotide exchanging factor (GEF) responsible for GDP/GTP exchange of RhoA and Rac1, we performed pull-down assays using aortas at the ages of 3 and 7 months. Fig. 5A, 5B show that the GTP-loading of RhoA and Rac1 of the aortas at the 7 months were significantly increased compared with at 3 months (n 6, p 0.005, each). Moreover, the activity of p47 phox was determined by membrane translocation, indicating that the activity of p47 phox of the aortas at 7 months was significantly increased approximately 2-fold compared with at 3 months (n 4, p 0.05, data not shown).
Effect of Oxidized LDL on Total Protein Levels of RhoA and Rac1 in Cultured SMCs
Finally, to clarify the influence of hyperlipidemia on RhoA and Rac1 metabolism in vitro, we examined the effect of oxidized LDL on the protein levels of RhoA and Rac1 in cultured rabbit SMCs. Incubation with oxidized LDL tended to increase the protein levels of RhoA and Rac1 in SMCs. Fig. 6 shows a significant increase in the protein levels of RhoA and Rac1 in SMCs stimulated with 25 g/mL oxidized LDL after 48 hours of incubation, but not 24 hours.
Discussion
The present study shows for the first time the profile of unprocessed and geranylgeranylated forms of RhoA and Rac1 with aging in the atherosclerotic lesions of a novel atherosclerosis animal model of WHHLMI rabbits, indicating that the amounts of unprocessed RhoA and Rac1 increased with cellular infiltration in the progression of atherosclerosis. Data also showed that the activities of RhoA and Rac1 were enhanced in atherosclerotic lesions with cellular infiltration at 7 months compared with early atherosclerotic lesions at 3 months. These findings suggest that the potency of the increased pool of unprocessed RhoA and Rac1 may play a role in the pathogenesis of 
atherosclerosis.
Although it has been reported that oxidized LDL and LPC activate RhoA in isolated rabbit aortas, which is involved in angiotensin -induced vasoconstriction, other studies have shown that spontaneously hypertensive rats have higher protein levels of RhoA in tail arteries than control rats 21, 22) . Moreover, vascular Rac1 has been shown to increase in atherogenic animal models in vivo 12, 23, 24) . The present study of WHHLMI rabbits clearly demonstrated that the aortic total RhoA and Rac1 levels increased in accordance with the proportions of unprocessed RhoA and Rac1 and the activities of the molecules in the progression of atherosclerosis. This was accompanied by cellular infiltration. Thus, our data showed decreases in total levels, unprocessed levels and the activities of RhoA and Rac1 at 15 and 24 months compared with at 7 months in accordance with the reduction of cellular components 17) . Our in vitro study also showed that a significant increase in total RhoA and Rac1 protein levels was induced by oxidized LDL in cultured SMCs, suggesting that hyperlipidemia increases total RhoA and Rac1 protein levels in the vascular wall.
Our previous data showed that the percentages of unprocessed and geranylgeranylated forms of RhoA are approximately 30% and 70% in cultured human aortic endothelial cells, respectively 9) ; however, little is known about the proportions of unprocessed and geranylgeranylated forms of RhoA and Rac in the vascular wall in vivo. In this study, we found that the proportions of unprocessed and geranylgeranylated forms of RhoA and Rac1 were almost similar to those in vitro in early atherosclerotic lesions. Unexpectedly, for the first time we found that the proportions of unprocessed RhoA and Rac1 were increased and reversed by those of geranylgeranylated RhoA and Rac1 in advanced atherosclerotic lesions.
We reported that certain stimulation directly converts almost all unprocessed RhoA into the membrane-bound active form of GTP-RhoA via geranylgeranylation, which exerts vascular responses, including endothelial dysfunction, increased permeability and thrombogenicity 9) . Thus, we expected that hyperlipidemia-dependent atherosclerotic lesions would have greater amounts of geranylgeranylated forms of RhoA and Rac1 than early atherosclerotic lesions; however, the results were the opposite, as described above. Since atherosclerotic lesions with increased cellular components have been characterized by RhoAdependent endothelial dysfunction and Rac1-dependent ROS generation 1, 11, 12, 23 24) , one of the possible implications of our findings is that the increase in the pool of unprocessed forms of RhoA and Rac1 may induce RhoA-and Rac1-dependent vascular responses to atherogenic stimuli. Another important factor may be the time interval of exposure to atherogenic stimuli. The results of in vitro experiments in our previous work and the current study were based on short-term exposure to thrombin and oxidized LDL 9) . And longterm exposure experiments might be required to resolve the issue. The detailed mechanisms by which the progression of atherosclerosis exerted increases in unprocessed RhoA and Rac1 remain to be elucidated.
Statins reportedly reduced atherosclerotic lesions with macrophage accumulation in the same animal model used in the present study and directly decreased tissue factor expression in macrophages, independent of lowering cholesterol 25) . We also showed that both hydrophilic and lipophilic statins suppress molecular expression, including tissue factor and plasminogen activator inhibitor-1, by depletion of cellular geranylgeranylpyrophosphate (GGPP) 16, [26] [27] [28] . Taken together with other reports [29] [30] [31] , our previous study clearly demonstrated the exact mechanism of the pleiotropic effect that statins rapidly blocks the activation of unprocessed GDP-RhoA by inhibiting geranylgeranylation 9) . The data from the present study that unprocessed RhoA and Rac1 of advanced atherosclerotic lesions increased may support the potency of the pharmacologial effect of statins, independent of lowering cholesterol. It may be that the more unprocessed RhoA and Rac1 there is, the more effective the statin treatment.
A study limitation was that we showed neither RhoA-dependent nor Rac1/p47 phox -dependent vascular responses in this study; however, decreased endothelial cell-dependent arterial relaxation has been demonstrated in WHHL rabbits, and increased superoxide production has been reported in atherosclerotic lesions of WHHL rabbits 32, 33) . Taken together, our results support RhoA-dependent endothelial dysfunction and Rac1-mediated ROS generation in the progression of atherosclerosis in this animal model. Another study limitation was that we could not demonstrate the relation between the increase in unprocessed RhoA and Rac1 in plaques and plaque instability using this novel WHHIMI model; this issue should be extensively investigated. Finally, we could not show the results of membrane translocation at 24 months and GTP-loading at 15 and 24 months due to the limited supply of WHHIMI rabbits since this animal model is valuable.
In conclusion, we provide evidence of marked increases in unprocessed RhoA and Rac1 with increased activity associated with the progression of atherosclerosis in WHHIMI rabbits. This may be the key to understanding the pathogenesis of hyperlipidemic-dependent atherosclerosis.
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